You are here:Home-Chemical Inhibitors & Agonists-Membrane Transporter/Ion Channel-Exportin-1 (CRM1,XPO1)-CBS9106
CBS9106

Chemical Structure : CBS9106

CAS No.: 1076235-04-5

CBS9106 (Felezonexor, SL-801)

Catalog No.: PC-23458Not For Human Use, Lab Use Only.

CBS9106 (Felezonexor) is a reversible oral CRM1/exportin1 inhibitor, inhibits CRM1-dependent nuclear export, causing arrest of the cell cycle and inducing apoptosis in a broad spectrum of cancer cells.

Packing Price Stock Quantity
2 mg $258 In stock
5 mg $428 In stock
10 mg $728 In stock
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

CBS9106 (Felezonexor) is a reversible oral CRM1/exportin1 inhibitor, inhibits CRM1-dependent nuclear export, causing arrest of the cell cycle and inducing apoptosis in a broad spectrum of cancer cells.
CBS9106 (Felezonexor) sensitize cells to radiation and to suppress the growth of a variety of cancer cell lines with IC50 values ranged from 22.3 or 35.6 nM in MM.1S or RPMI-8226 cells and from 3 to 278 nM in 60 other human cancer cell lines.
CBS9106 (Felezonexor) inhibits HIV Rev function with IC50 of 5.5 nM.
CBS9106 decreases CRM1 protein expression levels in MM.1S cells, inhibits NF-κB activity by protection against IκB-α degradation.
CBS9106-mediated CRM1 depletion requires ubiquitin/proteasome pathway.
CBS9106 directly binds to CRM1 in a competitive manner with Leptomycin B, binds Cys528 of CRM1 and the binding is reversible.
CBS9106 (Felezonexor) significantly suppresses tumor growth and prolongs survival in human MM xenograft models.

Physicochemical Properties

M.Wt 419.83
Formula C18H21ClF3N3O3
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

1-((6-Chloro-5-(trifluoromethyl)pyridin-2-yl)amino)-3-((3,3-dimethylbutoxy)methyl)-4-methyl-1H-pyrrole-2,5-dione

References

1. Saito N, et al. Mol Cancer Ther. 2014 Dec;13(12):3013-23.

2. Sakakibara K, et al. Blood. 2011 Oct 6;118(14):3922-31.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: